BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33882257)

  • 1. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
    George CX; Gan Z; Liu Y; Samuel CE
    J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX; John L; Samuel CE
    J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
    George CX; Ramaswami G; Li JB; Samuel CE
    J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
    Samuel CE
    J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
    Keegan LP; Hajji K; O'Connell MA
    Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
    Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
    RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.
    George CX; Samuel CE
    J Virol; 2011 Aug; 85(16):8338-47. PubMed ID: 21632755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-to-I editing of protein coding and noncoding RNAs.
    Mallela A; Nishikura K
    Crit Rev Biochem Mol Biol; 2012; 47(6):493-501. PubMed ID: 22988838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
    Liu Y; Emeson RB; Samuel CE
    J Biol Chem; 1999 Jun; 274(26):18351-8. PubMed ID: 10373439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.